Details for 2015798058
Up to date per 01.04.2026
Actions
Details for 2015798058
Deleted
European Patent
27.09.2017 A
12.01.2022 B1
19.11.2014
US
201462081742 P
A61M 15/08 20060101AFI20160530BHEP
Owner
Optinose ASPostboks 288 Røa 0702 OsloNO
Representative
No representatives present
Inventor
DJUPESLAND, Per Gislec/o OptiNose AS Postboks 288 Røa 0702 OsloNO
MAHMOUD, Ramy A.c/o OptiNose US Inc. 1010 Stony Hill Road Suite 375 Yardley Pennsylvania 19067US
ANDREASSEN, Ole A.c/o Norwegian Centre for Mental Disorders Research (Norment) KG Jebsen Centre for Psychosis Research Building 49 Oslo University Hospital Ullevål Kirkeveien 166 0424 OsloNO
WESTLYE, Lars T.c/o Norwegian Centre for Mental Disorders Research (Norment) KG Jebsen Centre for Psychosis Research Building 49 Oslo University Hospital Ullevål Kirkeveien 166 0424 OsloNO
QUINTANA, Daniel S.c/o Norwegian Centre for Mental Disorders Research (Norment) KG Jebsen Centre for Psychosis Research Building 49 Oslo University Hospital Ullevål Kirkeveien 166 0424 OsloNO
SMERUD, Knut T.c/o Smerud Medical Research International AS Drammensveien 41 0271 OsloNO
SHELDRAKE, Colin Davidc/o OptiNose UK Ltd. Berkeley House Hunts Rise South Marston Park Wiltshire SN3 4TGGB